홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

톨메틴

Tolmetin

HCID 5509
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
26171-23-3
표준 SMILES
Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1
InChIKey
UPSPUYADGBWSHF-UHFFFAOYSA-N
분자식
C15H15NO3
평균 분자량
257.28 g/mol
단동위원소 질량
257.10519334

개요

Tolmetin is a monocarboxylic acid that is (1-methylpyrrol-2-yl)acetic acid substituted at position 5 on the pyrrole ring by a 4-methylbenzoyl group. Used in the form of its sodium salt dihydrate as a nonselective nonsteroidal anti-inflammatory drug. It has a role as a non-steroidal anti-inflammatory drug and an EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor. It is a monocarboxylic acid, a member of pyrroles and an aromatic ketone. It is a conjugate acid of a tolmetin(1-).

이름 및 식별자

우선 이름
Tolmetin
IUPAC
2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetic acid
현지명
톨메틴
영어명
Tolmetin
분자식
C15H15NO3
분자량
257.28

이름 및 동의어

tolmetin26171-23-31-Methyl-5-p-toluoylpyrrole-2-acetic acidTolmetineTolectinTolmetinaTolmetinumTolmetinoMcN-25591H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-2-(1-METHYL-5-(4-METHYLBENZOYL)-1H-PYRROL-2-YL)ACETIC ACIDMCN 2559
이름 더 보기
톨메틴C07149olmetinMethyiinpyrolyzateTolmetin PrecursorTolmetin, 10 mM in DMSO
1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid5-(p-Toluoyl)-1-methylpyrrole-2-acetic acid2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acidD8K2JPN18BPyrrole-2-acetic acid, 1-methyl-5-p-toluoyl-DTXSID2043951CHEBI:719415-22-06-00392 (Beilstein Handbook Reference)

데이터베이스 식별자

CAS
26171-23-3
PubChem CID
5509
DTXSID
DTXSID2043951
ChEMBL
CHEMBL1020
ChEBI
CHEBI:71941

물성

구조 계산 물성

XLogP
2.8
극성 표면적
59.3 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
3
회전 가능 결합 수
4
무거운 원자 수
19
형식 전하
0
복잡도
347

실험 및 물리화학적 성질

Drugs · 2건

DEA NFLIS-Drug Category -> Analgesics

Pharmaceuticals -> Listed in ZINC15

LogP · 2건

2.6

2.79

Color/FormCRYSTALS FROM ACETONITRILE
Solubility1.31e-01 g/L
Human Drugs · 2건

Breast Feeding; Lactation; Milk, Human; Analgesic Agents; Anti-inflammatory Agents, Nonsteroidal

Pharmaceuticals

Melting Point · 2건

155-157 °C (DECOMPOSES)

156 °C

Physical DescriptionSolid
Dissociation Constants · 3건

3.5

3.5

3.5

Collision Cross Section · 2건

157.42 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

156.7 Ų [M+H]+ [CCS Type: TW]

Other Experimental Properties

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H301 (33.3%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Other Safety InformationIMAP assessments - 1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-: Environment tier I assessment
Special Reports · 3건

REVIEW ARTICLE INCLUDES TOLMETIN.[SIMON LS, MILLS JA; NONSTEROIDAL ANTIINFLAMMATORY DRUGS (SECOND OF TWO PARTS); N ENGL J MED 302 (22) 1237 (1980)]

TOLMETIN'S PHARMACOLOGICAL PROPERTIES & THERAPEUTIC EFFICACY IN RHEUMATIC DISEASES ARE REVIEWED.[BROGDEN RN ET AL; TOLMETIN: A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES & THERAPEUTIC EFFICACY IN RHEUMATIC DISEASES; DRUGS 15(6) 429 (1978)]

THE HISTORY OF RESEARCH & DEVELOPMENT OF NONSTEROIDAL ANTI-INFLAMMATORY AGENTS, INCL TOLMETIN.[GRINGAUZ A; NONSTEROIDAL ANTI-INFLAMMATORY AGENTS--ANYTHING NEW UNDER THE SUN?; HOSP FORMUL 14(MAR) 290 (1979)]

Hazard Classes and CategoriesAcute Tox. 3 (33.3%)

독성 정보

Interactions · 5건

PT RECEIVING CORTICOSTEROID OR GOLD THERAPY OBTAINED GREATER RELIEF OF SYMPTOMS WHEN TOLMETIN WAS ADDED TO THE REGIMEN, & THERE WAS EVIDENCE THAT TOLMETIN HAD A STEROID-SPARING EFFECT. /TOLMETIN SODIUM/

CONCOMITANT ADMIN OF TOLMETIN & ACETAMINOPHEN PRODUCED A GREATER IMPROVEMENT IN SYMPTOMS THAN WITH TOLMETIN ALONE, BUT FURTHER STUDIES ARE NEEDED TO SUBSTANTIATE THIS EFFECT. /TOLMETIN SODIUM/

화학 및 산업

약리 정보

ATC Code · 4건

M - Musculo-skeletal system

M - Musculo-skeletal system

QM - Musculo-skeletal system

QM - Musculo-skeletal system

Pharmacodynamics · 1건

Tolmetin is a nonsteroidal anti-inflammatory agent. Studies in animals have shown tolmetin to possess anti-inflammatory, analgesic and antipyretic activity. In the rat, tolmetin prevents the development of experimentally induced polyarthritis and also decreases established inflammation. In patients with either rheumatoid arthritis or osteaoarthritis, tolmetin is as effective as aspirin and indomethacin in controlling disease activity, but the frequency of the milder gastrointestinal adverse effects and tinnitus was less than in aspirin-treated patients, and the incidence of central nervous system adverse effects was less than in indomethacin-treated patients. In patients with juvenile rheumatoid arthritis, tolmetin is as effective as aspirin in controlling disease activity, with a similar incidence of adverse reactions. tolmetin has produced additional therapeutic benefit when added to a regimen of gold salts and, to a lesser extent, with corticosteroids. Tolmetin should not be used in conjunction with salicylates since greater benefit from the combination is not likely, but the potential for adverse reactions is increased.

Mechanism of Action · 3건

The mode of action of tolmetin is not known. However, studies in laboratory animals and man have demonstrated that the anti-inflammatory action of tolmetin is not due to pituitary-adrenal stimulation. Tolmetin inhibits prostaglandin synthetase in vitro and lowers the plasma level of prostaglandin E in man. This reduction in prostaglandin synthesis may be responsible for the anti-inflammatory action. Tolmetin does not appear to alter the course of the underlying disease in man.

ALTHOUGH IT DIFFERS CHEMICALLY FROM ASPIRIN & OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS, ITS PHARMACOLOGIC PROPERTIES ARE SIMILAR. /TOLMETIN SODIUM/

...INHIBITS PROSTAGLANDIN SYNTHETASE IN VITRO. IT ALSO HAS BEEN SHOWN TO LOWER PLASMA LEVEL OF PROSTAGLANDIN E IN MAN. HOWEVER, SIGNIFICANCE OF THESE ACTIONS IN RELATION TO CLINICAL EFFECTS IS NOT KNOWN. /TOLMETIN SODIUM/

Biological Half-LifeBiphasic elimination from the plasma consisting of a rapid phase with a half-life of one to 2 hours followed by a slower phase with a half-life of about 5 hours.

관련 반응

19건
반응 기록 만들기
HRID 286915 반응식
HRID 286915생성물로
HRID 365603 반응식
HRID 365603반응물로
HRID 365619 반응식
HRID 365619반응물로
HRID 369384 반응식
HRID 369384반응물로
HRID 369401 반응식
HRID 369401반응물로
HRID 483239 반응식
HRID 483239반응물로
HRID 618319 반응식
HRID 618319반응물로
HRID 618335 반응식
HRID 618335반응물로
이전1 / 3 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
UNII
D8K2JPN18B
EC Number
247-497-2
Nikkaji
J20.519B
PYRROLE-ACETIC ACID DERIVATIVE /TOLMETIN SODIUM/

물리화학적 성질

녹는점
156 °C · 156 °C
끓는 점
400.53 °C · 400.53°C (rough estimate)
밀도
1.1391 · 1.1391 (rough estimate)
굴절률
1.52 · 1.5200 (estimate)
저장 조건
2 · 2-8°C
용해도
클로로포름(약간 용해됨), 메탄올(약간 용해됨)
산도 계수 (pKa)
3.5 · pKa 3.5(H2O t undefined I undefined) (Uncertain)
물리적 상태
고체
색상
황백색에서 연한 노란색
수용성
222 mg/L · 222mg/L
InChI
InChI=1S/C15H15NO3/c1-10-3-5-11(6-4-10)15(19)13-8-7-12(16(13)2)9-14(17)18/h3-8H,9H2,1-2H3,(H,17,18)
InChIKey
UPSPUYADGBWSHF-UHFFFAOYSA-N
SMILES
N1(C)C(C(=O)C2=CC=C(C)C=C2)=CC=C1CC(O)=O
NIST
Tolmetin(26171-23-3)
EPA
1 H-Pyrrole-2-acetic · 1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)- (26171-23-3)

CONCOMITANT ASPIRIN REDUCES PLASMA LEVELS OF TOLMETIN BY ABOUT 20%, BUT THE INTERACTION PROBABLY IS NOT CLINICALLY IMPORTANT. /TOLMETIN SODIUM/

IN DOGS, PROSTAGLANDIN SYNTHETASE INHIBITORS INDOMETHACIN & TOLMETIN BLOCKED FUROSEMIDE-INDUCED INCR IN RENIN SECRETION WHETHER FUROSEMIDE WAS GIVEN IV OR INTO RENAL ARTERY.

DESPITE ITS EXTENSIVE BINDING TO ALBUMIN...NO CHANGE IN PROTHROMBIN TIME WHEN WARFARIN & TOLMETIN WERE GIVEN TOGETHER.

HepatotoxicityUp to 5% of patients taking tolmetin chronically experience at least transient serum aminotransferase elevations. These may resolve even with drug continuation. Marked aminotransferase elevations (>3 fold elevated) occur in
Human Toxicity Excerpts · 5건

MOST FREQUENTLY REPORTED ADVERSE REACTIONS ARE GI DISTURBANCES... EPIGASTRIC DISTRESS, INCL HEARTBURN, DYSPEPSIA, & ABDOMINAL PAIN, WAS MOST COMMON; OTHER REACTIONS INCL NAUSEA, VOMITING, & CONSTIPATION. GI BLEEDING WAS REPORTED OCCASIONALLY... IN CLINICAL STUDIES, PEPTIC ULCER OCCURRED IN APPROX 2% OF PT. /TOLMETIN SODIUM/

CNS REACTIONS REPORTED INCL HEADACHE, DIZZINESS, LIGHTHEADEDNESS, NERVOUSNESS, & DROWSINESS. ... OTHER REACTIONS OBSERVED OCCASIONALLY WERE RASH OR URTICARIA, PRURITUS, TINNITUS, & MILD EDEMA, WHICH WAS RELATED TO SODIUM RETENTION. /TOLMETIN SODIUM/

THE CASE OF A 51-YR-OLD MAN WHO DEVELOPED ANAPHYLAXIS AFTER RESTARTING ORAL THERAPY WITH TOLMETIN SODIUM FOR A PULLED GROIN MUSCLE IS PRESENTED.

A 56-YR-OLD MAN WITH RHEUMATOID ARTHRITIS, BEING TREATED WITH TOLMETIN SODIUM 1800 MG/DAY, DEVELOPED A DRUG FEVER BELIEVED TO BE DUE TO TOLMETIN SODIUM THERAPY.

For more Human Toxicity Excerpts (Complete) data for TOLMETIN (9 total), please visit the HSDB record page.

Drug Induced Liver Injury · 5건

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

tolmetin

DILI Positive

Oral

DOI:10.1016/j.drudis.2019.09.022

Non-Human Toxicity Excerpts · 2건

MAX ANTIINFLAMMATORY ACTIVITY OF RECTALLY ADMIN TOLMETIN WAS OBSERVED IN RATS AFTER 125 MG/KG DOSE. TOLMETIN ALSO SHOWED GREATER ACTIVITY WHEN ADMIN RECTALLY THAN ORALLY. THE LD50 OF RECTALLY ADMIN TOLMETIN WAS 743.6 MG/KG IN MALE & 843.4 MG/KG IN FEMALE RATS.

TOLMETIN (100-150 MUG/L) DOSE-DEPENDENTLY INHIBITED DNA SYNTHESIS BY MOUSE SPLEEN CELLS & HUMAN LYMPHOCYTES IN VITRO.

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

안전 데이터

유해 물질 데이터
26171-23-3(Hazardous Substances Data)
Metabolism/Metabolites · 3건

Essentially all of the administered dose is recovered in the urine in 24 hours either as an inactive oxidative metabolite or as conjugates of tolmetin.

URINE METABOLITES 1-METHYL-5-(4-CARBOXYBENZOYL)-1H-PYRROLE-2-ACETIC ACID & TOLMETIN GLUCURONIDE NOTED AFTER TOLMETIN SODIUM.

Tolmetin has known human metabolites that include Tolmetin glucuronide.

FDA Pharmacological Classification · 6건

D8K2JPN18B

TOLMETIN

Mechanisms of Action [MoA] - Cyclooxygenase Inhibitors

Chemical Structure [CS] - Anti-Inflammatory Agents, Non-Steroidal

Established Pharmacologic Class [EPC] - Nonsteroidal Anti-inflammatory Drug

Tolmetin is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of tolmetin is as a Cyclooxygenase Inhibitor.

MeSH Pharmacological Classification · 2건

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.

Absorption, Distribution and Excretion · 6건

Rapidly and almost completely absorbed with peak plasma levels being reached within 30-60 minutes after an oral therapeutic dose.

THE DRUG IS RAPIDLY ABSORBED AFTER ORAL ADMIN, PEAK PLASMA LEVELS OCCUR IN 30 TO 60 MIN. IT IS EXCRETED LARGELY IN URINE, PRIMARILY AS CONJUGATES OR METABOLITES. ITS PLASMA HALF-LIFE IS APPROX 1 HR. /TOLMETIN SODIUM/

GI ABSORPTION IS ABOUT 90% OR GREATER...WITH PEAK LEVELS WITHIN 20-60 MIN FOR TOLMETIN... PROTEIN BINDING IS EXTENSIVE, BEING 90% OR GREATER... HEPATIC BIOTRANSFORMATION & RENAL EXCRETION WITH SOME FECAL EXCRETION OF METABOLITES ARE THE MEANS OF ELIMINATION. /TOLMETIN SODIUM/

TOLMETIN IS RAPIDLY & COMPLETELY ABSORBED FOLLOWING ORAL ADMIN TO MAN, & CONCN ACHIEVED IN PLASMA ARE NOT REDUCED BY CONCOMITANT ADMIN OF GASTRIC ANTACIDS. PEAK CONCN ARE ACHIEVED 20-60 MIN AFTER ORAL ADMIN, & T/2 IN PLASMA IS BETWEEN 1 & 3 HR.

AFTER ABSORPTION, TOLMETIN IS EXTENSIVELY (99%) BOUND TO PLASMA PROTEINS. VIRTUALLY ALL OF THE DRUG CAN BE RECOVERED IN URINE AFTER 24 HR; SOME IS UNCHANGED (17%), BUT MOST IS CONJUGATED (10%) OR OTHERWISE METABOLIZED. THE MAJOR METABOLITE TRANSFORMATION IS DECARBOXYLATION.

TOLMETIN SODIUM WAS RAPIDLY & COMPLETELY ABSORBED (PEAK TIME, 20-60 MIN) & ELIMINATED RAPIDLY FROM PLASMA WITH BIPHASIC DECAY CURVE & ELIMINATION T/2 OF APPROX 2.1 HR.

Cellular LocationsCytoplasm
Metabolite PathwaysTolmetin Action Pathway

용도 및 제조

UsesMEDICATION
Methods of ManufacturingCARSON, FRENCH PATENT 1,574,570 (1969 TO MCNEIL LABS), CA 72, 100498Y (1969). PHARMACOLOGY: CARSON ET AL, J MED CHEM 14, 646 (1971); WONG ET AL, J PHARMACOL EXP THER 185, 127 (1973).
Formulations/PreparationsTOLECTIN (MCNEIL), ORAL: TABLETS 200 MG. /TOLMETIN SODIUM/
Use ClassificationPharmaceuticals
응용 분야 · 3건

개요An antiinflammatory, analgesic, and antipyretic that is as efficacious as moderate doses of aspirin and better tolerated. Tolmetin produces a number of adverse effects including epigastric pain, dyspepsia, nausea, and vomiting. Tolmetin is approximately 99% plasma protein bound, yet does not interfere with concurrent treatment with oral hypoglycemics. Tolmetin has been found to be effective in the treatment of osteoarthritis and rheumatoid arthritis.

용도Tolmetine is an NSAID.

일반 설명Tolmetin sodium (Tolectin), is an arylacetic acid derivativewith a pyrrole as the aryl group. This drug is well absorbed and has a relatively short plasma half-life (1 hour). It is recommendedfor use in the management of acute and chronicRA. Its efficacy is similar to aspirin and indomethacin, butwith less frequency of the adverse effects and tinnitus associatedwith aspirin. It does not potentiate coumarin-likedrugs nor alter the blood levels of sulfonylureas or insulin.However, tolmetin, and especially its closely related drug,zomepirac (i.e., with a p-chlorobenzoyl group and an additionalmethyl group on the pyrrole ring), can produce a rarebut fatal anaphylactic reaction because of irreversible bindingof their unstable acyl glucuronides. Zomepirac waswithdrawn from market because it is eliminated only via theester-type, acyl glucuronide. It is possible that tolmetin isless toxic in this regard because it undergoes additional hepaticbenzylic hydroxylation via its p-methyl group and isexcreted as its stable ether glucuronide.

상·하류 제품 정보

상류 원료

p-톨루오일 염화물수산화나트륨1-Methylpyrrole-2-acetonitrile염화알루미늄
추가 설명 · 1건

정의ChEBI: A monocarboxylic acid that is (1-methylpyrrol-2-yl)acetic acid substituted at position 5 on the pyrrole ring by a 4-methylbenzoyl group. Used in the form of its sodium salt dihydrate as a nonselective nonsteroidal anti-inflammatory drug.